Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Retained Earnings (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Retained Earnings for 2 consecutive years, with -$578.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings changed N/A to -$578.9 million in Q4 2025 year-over-year; TTM through Oct 2025 was -$578.9 million, a N/A change, with the full-year FY2025 number at -$520.2 million, down 28.0% from a year prior.
  • Retained Earnings was -$578.9 million for Q4 2025 at Kestra Medical Technologies, down from -$546.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$406.4 million in Q2 2024 to a low of -$578.9 million in Q4 2025.